Hemanext Announces a Strategic Partnership and Investment from Vitalant

June 14, 2023

Hemanext Inc., an AABB premium corporate partner, last week announced a new partnership with Vitalant, an AABB institutional member and one of the nation’s largest nonprofit blood and biotherapies health care organizations. This strategic partnership includes an initial investment by Vitalant and research collaboration through the new Vitalant Innovation Center, which provides scientific research and translational development expertise to design innovative processes and bring new products to patients across the country.